Table 2.
Term and setting | Measure | Temporality | sCr or eGFR | Other criteria |
---|---|---|---|---|
AKI (acute HF) | Relative sCr | Within 1–7 days before or during hospitalization |
|
Deterioration in heart failure status or failure to improve or requirement of inotropic support, UF, or RRT |
Absolute sCr | Within 48 hours |
|
Deterioration in heart failure status or failure to improve or requirement of inotropic support, UF, or RRT | |
Urine output | Over 6–12 hours |
|
Deterioration in heart failure status or failure to improve or requirement of inotropic support, UF, or RRT | |
Pseudo-AKI (acute HF) | Multiple | Within 1–7 days before or during hospitalization | Not meeting | AKI criteria* |
WRF (Chronic HF) | Absolute and relative sCr | Over 1–26 weeks |
|
Deterioration in HF status but not leading to hospitalization |
eGFR | Over 1–26 weeks |
|
Deterioration in HF status but not leading to hospitalization | |
Pseudo-WRF | Multiple | Over 1–26 weeks | Not meeting | WRF criteria* |
AKI definitions do not include eGFR because eGFR calculations assume steady-state renal function.
AKI, acute kidney injury; eGFR, estimated glomerular filtration rate; HF, heart failure; RRT, renal replacement therapy; sCr, serum creatinine; UF, ultrafiltration; WRF, worsening renal function.
Damman et al.3 suggest that doubling or a > 88.4 μmol/L rise in serum creatinine should trigger further investigation even if falling into the pseudo-AKI or pseudo-WRF categories.
Modified from Damman et al.3 with permission from Oxford University Press.